Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
- PMID: 28404095
- PMCID: PMC5495015
- DOI: 10.1016/S2468-1253(16)30106-6
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
Abstract
Diabetes mellitus is a group of diseases defined by persistent hyperglycaemia. Type 2 diabetes, the most prevalent form, is characterised initially by impaired insulin sensitivity and subsequently by an inadequate compensatory insulin response. Diabetes can also develop as a direct consequence of other diseases, including diseases of the exocrine pancreas. Historically, diabetes due to diseases of the exocrine pancreas was described as pancreatogenic or pancreatogenous diabetes mellitus, but recent literature refers to it as type 3c diabetes. It is important to note that type 3c diabetes is not a single entity; it occurs because of a variety of exocrine pancreatic diseases with varying mechanisms of hyperglycaemia. The most commonly identified causes of type 3c diabetes are chronic pancreatitis, pancreatic ductal adenocarcinoma, haemochromatosis, cystic fibrosis, and previous pancreatic surgery. In this Review, we discuss the epidemiology, pathogenesis, and clinical relevance of type 3c diabetes secondary to chronic pancreatitis and pancreatic ductal adenocarcinoma, and highlight several important knowledge gaps.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Conflict of interest statement
MDB has received research support outside of the submitted work from Merck & Co, Medtronic, and Dompe pharmaceuticals. STC has received research support outside of the submitted work from Sandler Kenner Foundation, and non-financial support from Kenner Family Research Fund. PAH has received honoraria from Abbvie, as well as consulting fees from KC Specialty Therapeutic. SJP has received research support outside of the submitted work from Calcimedica, and has patents licensed, issued, and pending for intellectual property that is unrelated to the submitted work. DY is consulting for Abbvie and has received royalties for UpToDate publication. DKA, DB, ZC-M, CEF, MOG, AH, MK, and YCK declare no competing interests.
Figures
Similar articles
-
A tale of two pancreases: exocrine pathology and endocrine dysfunction.Diabetologia. 2020 Oct;63(10):2030-2039. doi: 10.1007/s00125-020-05210-8. Epub 2020 Sep 7. Diabetologia. 2020. PMID: 32894313 Free PMC article. Review.
-
The complex exocrine-endocrine relationship and secondary diabetes in exocrine pancreatic disorders.J Clin Gastroenterol. 2011 Nov-Dec;45(10):850-61. doi: 10.1097/MCG.0b013e31822a2ae5. J Clin Gastroenterol. 2011. PMID: 21897283 Review.
-
Negotiating the complexities of exocrine and endocrine dysfunction in chronic pancreatitis.Proc Nutr Soc. 2017 Nov;76(4):484-494. doi: 10.1017/S0029665117001045. Epub 2017 Jul 24. Proc Nutr Soc. 2017. PMID: 28735575 Review.
-
The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis.Eur J Clin Nutr. 2017 Jan;71(1):3-8. doi: 10.1038/ejcn.2016.127. Epub 2016 Jul 13. Eur J Clin Nutr. 2017. PMID: 27406162 Review.
-
Complications of Chronic Pancreatitis.Dig Dis Sci. 2017 Jul;62(7):1745-1750. doi: 10.1007/s10620-017-4518-x. Epub 2017 Mar 9. Dig Dis Sci. 2017. PMID: 28281169 Free PMC article. Review.
Cited by
-
Circulating miRNA in Patients Undergoing Total Pancreatectomy and Islet Autotransplantation.Cell Transplant. 2021 Jan-Dec;30:963689721999330. doi: 10.1177/0963689721999330. Cell Transplant. 2021. PMID: 33902338 Free PMC article.
-
Development of a Clinical Prediction Model for Diabetes in Chronic Pancreatitis: The PREDICT3c Study.Diabetes Care. 2023 Jan 1;46(1):46-55. doi: 10.2337/dc22-1414. Diabetes Care. 2023. PMID: 36382801 Free PMC article.
-
Hemifacial Spasm as the Presenting Manifestation of Type 3c Diabetes Mellitus.Tremor Other Hyperkinet Mov (N Y). 2021 Apr 26;11:14. doi: 10.5334/tohm.611. Tremor Other Hyperkinet Mov (N Y). 2021. PMID: 33981477 Free PMC article.
-
Outcomes of Islet Autotransplantation in Chronic Pancreatitis Patients with Complete Acinar Atrophy.Cell Transplant. 2020 Jan-Dec;29:963689720949242. doi: 10.1177/0963689720949242. Cell Transplant. 2020. PMID: 32878466 Free PMC article.
-
Quantitative Metabolomics and Lipoprotein Analysis of PDAC Patients Suggests Serum Marker Categories for Pancreatic Function, Pancreatectomy, Cancer Metabolism, and Systemic Disturbances.J Proteome Res. 2024 Apr 5;23(4):1249-1262. doi: 10.1021/acs.jproteome.3c00611. Epub 2024 Feb 26. J Proteome Res. 2024. PMID: 38407039
References
-
- American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;39(suppl 1):S13–22. - PubMed
-
- Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S5–20. - PubMed
-
- Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c) Diabetes Metab Res Rev. 2012;28:338–42. - PubMed
-
- Xiao AY, Tan MLY, Wu LM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016 published online June 28. http://dx.doi.org/10.1016/S2468-1253(16)30004-8. - DOI - PubMed
-
- Yadav D, Timmons L, Benson JT, Dierkhising RA, Chari ST. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol. 2011;106:2192–99. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 DK108288/DK/NIDDK NIH HHS/United States
- U01 DK108323/DK/NIDDK NIH HHS/United States
- I01 BX001484/BX/BLRD VA/United States
- P01 DK098108/DK/NIDDK NIH HHS/United States
- P01 CA163200/CA/NCI NIH HHS/United States
- P30 DK097512/DK/NIDDK NIH HHS/United States
- U01 DK108300/DK/NIDDK NIH HHS/United States
- U01 DK108306/DK/NIDDK NIH HHS/United States
- U01 DK108314/DK/NIDDK NIH HHS/United States
- U01 DK108327/DK/NIDDK NIH HHS/United States
- P50 AA011999/AA/NIAAA NIH HHS/United States
- U01 DK108320/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical